Neurocrine Biosciences is set to pay Voyager Therapeutics $165 million upfront for the rights to a clutch of gene therapies. The deal sees Neurocrine ... read more
Neurocrine pays Voyager $165M for neurological gene therapies
Neurocrine pays Voyager $165M for neurological gene therapies